You are here

  • Home
  • Archive
  • Volume 1, Issue 5
  • The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing

Article metrics

Article menu
Download PDFPDF
Original Article
The ‘failure free interval’ defines the likelihood of resistance to carboplatin in patients with advanced epithelial ovarian cancer previously treated with cisplatin: relevance to therapy and new drug testing

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2024

AbstractFullPdf
Jan 20191001
Feb 20192804
Mar 20191000
Apr 20191200
May 2019803
Jun 2019800
Jul 2019801
Aug 20192400
Sep 2019600
Oct 2019800
Nov 2019400
Dec 2019400
Jan 20201200
Feb 20201200
Mar 2020200
Apr 2020400
May 20201000
Jun 20201000
Jul 20201400
Aug 2020400
Sep 20201002
Oct 2020800
Nov 2020200
Dec 2020500
Jan 20211400
Mar 20211000
May 2021100
Oct 20211200
Nov 2021200
Dec 20211000
Jan 20221000
Feb 20221000
Mar 20221800
Apr 20221200
May 20223800
Jun 20223000
Jul 20222800
Aug 20223200
Sep 20225401
Oct 20224400
Nov 20221600
Dec 2022800
Jan 20231800
Feb 20236200
Mar 2023500
May 2023800
Jun 2023200
Jul 2023400
Aug 2023400
Sep 2023200
Oct 20231000
Nov 2023200
Dec 20234400
Jan 2024400
Feb 20241200
Mar 2024801
Apr 20241202
Total769015